Ankara City Hospital
Ankara, 06800, Turkey (Türkiye)
NCT Number: NCT06137456
The goal of this clinical trial is to compare the effects of exoskeletal robotic therapy and conventional exercise therapy in incomplete spinal cord injury (SCI). The main questions it aims to answer are:
* Is exoskeletal robotic therapy effective in improving functional ambulation in SCI? * Is exoskeletal robotic therapy effective in enhancing Activities of Daily Living in SCI?
Participants treated with either:
* Exoskeletal robotic therapy along with conventional exercise therapy, or * Only conventional exercise therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ankara, 06800, Turkey (Türkiye)
Background: Intensive walking practice is a task that requires performance above the limits of conventional therapy. As a solution, robot-assisted exoskeletons that allow walking on the ground are produced. The exoskeletons can allow the user to perform intense, targeted, and multi-repetitive movements and at the same time provide stability and balance during walking. In this study, a new robot-supported exoskeleton system was used for gait and balance rehabilitation. This study is important as the first clinical study of a new walking system. The primary aim of the study was to evaluate the effect of the FreeGait® exoskeleton system (BAMA Technology, Ankara, Türkiye) on gait parameters in patients with motor incomplete spinal cord injury. The secondary aim was to assess its impact on quality of life and independence.
Methods: Fourteen participants with incomplete spinal cord injury were included in the study. An average of 20.7 sessions of exoskeleton therapy was administered to the study group. Gait training was attempted to be diversified as much as possible during the exoskeleton training. 10MWT, Timed Up and Go Test (TUG), WISCI II, Berg Balance Scale (BBS), Visual Analogue Scale (VAS) for fear of falling, Spinal Cord Independence Measure (SCIM III), World Health Organization Quality of Life Scale-Short Form (WHOQOL - BREF) were used for evaluation.
Results: WISCI II levels improved significantly in the study group (p = 0.031). Overground walking speed means calculated from 10MWT increased by 66%, twofold compared to the control group (p = 0.016, p = 0.063, respectively). The mobility subscale of SCIM III, the total SCIM III scores, and the WHOQOL-BREF physical health domain score increased significantly, contrary to the control group (p < 0.05). However, there was no difference in the mean change of all measurements between groups (p > 0.05).
Conclusions: Gait training with the new exoskeleton system contributes to functional walking skills. It is possible that the residual motor learning ability, together with the balance and compensation mechanisms, played a role in the outcome. It is also important that this improvement in functional mobility is reflected in ADLs. It can be supposed that walking in different patterns, and speeds gives a way to simulate daily living conditions, which is the basis of the achievements in this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exoskeletal robotic therapy for walking. Therapy sessions were scheduled for 40 minutes each. The study group performed exoskeleton walking and balance exercises 3 days a week.
Conventional treatment consisted of walking and balance exercises, stretching, strengthening, and mobility exercises, for 40 minutes, 5 days a week.
Time frame: 23 months
Walking Index in Spinal Cord Injury II for walking independence level assessment
Time frame: 23 months
Ten-Meter Walking Test for overground walking speed assessment
Time frame: 23 months
Timed Up and Go Test overground walking assessment
Time frame: 23 months
Berg Balance Scale for balance assessment
Time frame: 23 months
Visual Analogue Scale (VAS) for fear of falling assessment
Time frame: 23 months
Spinal Cord Independence Measure (SCIM III) for activity of daily living assessment
Time frame: 23 months
World Health Organization Quality of Life Scale-Short Form (WHOQOL - BREF) for quality of life assessment
Ankara City Hospital Bilkent
Other
First Report of a New Exoskeleton in Incomplete Spinal Cord Injury: FreeGait®
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06137443
Central Nervous System Diseases, Mobility Limitation
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04460872
Androgen Deficiency, Bone Diseases
Gainesville, Florida, United States
View Trial DetailsNCT05473676
Brain Damage, Chronic, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT07705906
Brain Diseases, Cardiovascular Diseases
Dhaka, Dhaka Division, Bangladesh
View Trial Details